Streptococcus pneumoniae proteins and nucleic acid molecules

Details Streptococcus pneumoniae proteins and nucleic acid molecules Streptococcus pneumoniae proteins and nucleic acid molecules

2007-04-18

2009-12-15

Mondesi, Robert B (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S184100, C424S190100, C435S069700, C435S252300, C435S320100, C536S023700, C530S350000

Reexamination Certificate

active

07632515

ABSTRACT:
Protein antigens fromStreptococcus pneumoniaeare disclosed, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.

REFERENCES:
patent: 6420135 (2002-07-01), Kunsch et al.
patent: 6573082 (2003-06-01), Choi et al.
patent: 6699703 (2004-03-01), Doucette-Stamm et al.
patent: 6800744 (2004-10-01), Doucette-Stamm et al.
patent: 6936252 (2005-08-01), Gilbert et al.
patent: 0622081 (1994-11-01), None
patent: 1 785 486 (2007-05-01), None
patent: WO 95/06732 (1995-03-01), None
patent: WO 97/09994 (1997-03-01), None
patent: WO 97/37026 (1997-10-01), None
patent: WO 97/43303 (1997-11-01), None
patent: WO 98/06734 (1998-02-01), None
patent: WO 98/18930 (1998-05-01), None
patent: WO 98/18931 (1998-05-01), None
patent: WO 98/26072 (1998-06-01), None
patent: WO 98/31786 (1998-07-01), None
patent: WO 99/15675 (1999-04-01), None
Lederman et al (Molecular Immunology 28:1171-1181, 1991.
Li et al (Proc. Natl. Acad. Sci. USA 77:3211-3214, 1980).
Boslego et al, Chapter 17 in Vaccines and Immunotherapy 1991.
Houghten et al. (Vaccines, 1986, Edited by Fred Brown: Cold Spring Harbor Laboratory).
Anderson et al. (1996) “Immune Response in mice following immunization with DNA encoding fragment C of tetanus toxin.” Infection and Immunity 64: 3168-3173.
Angel, et al. (1994) “Degradation of C3 byStreptococcus pneumoniae.” Journal of Infectious Disease 170(3): 600-608.
Alonsodevelasco, et al. (Dec. 1995) “Streptococcus pneumoniae: Virulence Factors, Pathogenesis, and Vaccines.” Microbiological Reviews 59(4): 591-603.
Breiman et al. (1990) Arch. Intern. Med. 150: 1401.
Breiman et al. (1994) J. Am. Med. Assoc. 271: 1831.
Bowie (1990) Science 257: 1306-1310.
Burgess, et al. (1990) The Journal of Cell Biology 111: 2129-2136.
Donnelly et al. (1997) Ann. Rev. Immunol. 15: 617-648.
Dougall et al. (Sep. 1994) Tibtech 12: 372-379.
Ellis (1988) Vaccines Chapter 29: 568-575.
Greenspan, et al. (1999) Nature Biotechnology 7: 936-937.
Herbert, et al. (1985) The Dictionary of Immunology (Academic Press) 3rdEd. pp. 58-59.
Holmes, et al. (2001) Exp. Opin. Invest. Drugs 10(3): 511-519.
Jobling et al. (1991) Mol. Microbiol 5(7): 1755-67.
Kohler & Milstein (1975) Nature 256.
Kolkman et al. (1996) 178: 3736-3741.
Kovacevic et al. (1985) J. Bacteriol. 162: 521-528.
Kurar and Splitter (1997) Vaccine 15: 1851-57.
Lange et al. (Sep. 3, 1999) Gene 237(1): 223-234.
Lazar et al. (1988) Molecular and Cellular Biology 8(3): 1247-1252.
Le Loir et al. (1994) J. Bacteriol. 176: 5135-5139.
LeBlanc et al. (1978) PNAS USA 75: 3484-3487.
Li et al. (1997) PNAS 94: 13251-13256.
Liebl et al. (1992) J. Bacteriol. 174: 1854-1861.
Marck (1988) Nucleic Acids Research 16: 1829-1836.
Miller et al. (1987) J. Bacteriol. 169: 3508-3514.
Morrison et al. (1984) PNAS 81: 6851-6855.
Nanidwada, et al. (1996) “Genetic Analysis of a C3 degrading proteinase inSteptococcus pneumoniae.” Abstracts of the General Meeting of the American Society for Microbiology vol. 96 p. 177 (Abstract B-134).
Oultram and Klaenhammer (1985) FEMS Microbiological Letters 27: 129-134.
Pearson et al. (1988) “Improved tools for biological sequence comparison,” Proc. Natl. Acad. Sci. USA, vol. 85, 2444-2448.
Poquet et al. (1998) J. Bacteriol. 180: 1904-1912.
Roitt, et al. (1993) Immunology p. 7.7-7.8.
Rudinger et al. (Jun. 1976) “Peptide Hormones” p. 6.
Schappert (1992) Vital and Health Statistics of the Centres for Disease Control/National Centre for Health Statistics 214: 1.
Shortle (1983) Gene 22: 181-189.
Siber (Sep. 1994) “Pneumococcal Disease: Prospects for a New Generation of Vaccines” Science vol. 265, pp. 1385-1387.
Simon and Chopin (1988) Biochimie 70: 559-567.
Stansfield (1987) “Acute respiratory infections in the developing world: strategies for prevention, treatment and control,” Pediatric Infect Dis. Journal, vol. 6, 622-629.
Takeda et al. (1985) Nature 314: 452-454.
Taber's Cyclopedic Medical Dictionary (1985) 16thEd. p. 1354.
van der Vossen, et al. (1985) Applied and Environmental Microbiology 50: 540-542.
Waterfield et al. (1995) Gene 165: 9-15.
Wells and Schoefield (1996) In Current advances in metabolism, genetics, and applications-NATO ASI Series H 98: 37-62.
Wells et al. (1993) J. Appl. Bacteriol. 74: 629-636.
Zhang et al. (1997) Infection and Immunity 176: 1035-1040.
Nandiwada, et al. (1996) “Genetic Analysis of a C3 degrading proteinase inSteptococcus pneumoniae.” Abstracts of the General Meeting of the American Society for Microbiology vol. 96 p. 177 (Abstract B-134).

Affiliated with

Also associated with

Rating

Streptococcus pneumoniae proteins and nucleic acid molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Streptococcus pneumoniae proteins and nucleic acid molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus pneumoniae proteins and nucleic acid molecules will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4061680